Group IVD sPLA2 Activators encompass a range of chemical compounds that indirectly enhance the enzyme's activity by influencing various cellular and biochemical pathways. Arachidonic Acid, as a direct substrate for group IVD sPLA2, amplifies the enzyme's action by providing more substrate for its catalytic process, thereby enhancing its role in the inflammatory response. The function of group IVD sPLA2 is also heightened by Calcium Ionophore A23187, which increases intracellular calcium concentrations essential for the enzyme's activity. Bromoenol lactone and Methyl Arachidonyl Fluorophosphonate, by inhibiting competing phospholipases, indirectly allow for an increased activity of group IVD sPLA2 due to reduced substrate competition. Prostaglandin E2 and Leukotriene B4, both inflammatory mediators produced from arachidonic acid, enhance group IVD sPLA2 activity by inducing inflammation, which in turn, stimulates signaling pathways that the enzyme participates in.
Additionally, Melittin and Lysophosphatidylcholine act on cellular membranes to alter their structure and curvature, respectively, which can facilitate the access of group IVD sPLA2 to its phospholipid substrates. Platelet-Activating Factor enhances its activity by engaging in inflammatory responses wherein group IVD sPLA2 functions. The presence of 4-BromophenacylBromide and Oleic Acid can lead to an altered membrane environment, which may increase substrate accessibility for group IVD sPLA2, resulting in an enhancement of its activity. Lastly, U73122's inhibition of phospholipase C may shift intracellular signaling dynamics, potentially upregulating group IVD sPLA2 activity as part of a compensatory cellular response. Collectively, these activators, through their distinct mechanisms, contribute to the increased functional activity of group IVD sPLA2 by optimizing substrate availability, modulating membrane composition, and influencing related signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
As a substrate for group IVD sPLA2, arachidonic acid is released from membrane phospholipids upon the enzyme's activation. This release is part of the inflammatory response, indirectly enhancing the activity of group IVD sPLA2 by providing more substrate for it to act upon, thus amplifying its enzymatic function. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium levels, which are essential for group IVD sPLA2 activation, as the enzyme requires high calcium concentrations for its catalytic activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 can induce inflammation, which leads to the activation of signaling pathways that stimulate group IVD sPLA2, thereby increasing its activity and the production of arachidonic acid metabolites. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
As a product of arachidonic acid metabolism, leukotriene B4 can act in an autocrine or paracrine manner to enhance the activity of group IVD sPLA2, which is involved in its biosynthetic pathway. | ||||||
Melittin | 37231-28-0 | sc-200868 sc-200868A sc-200868B | 500 µg 1 mg 10 mg | $196.00 $339.00 $787.00 | 2 | |
Melittin, a peptide from bee venom, can activate group IVD sPLA2 by integrating into cellular membranes and altering their structure, which enhances the enzyme's access to phospholipid substrates. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid can incorporate into cellular membranes, altering their fluidity and potentially making the phospholipid substrates more accessible to group IVD sPLA2, thereby enhancing its activity. | ||||||
MAFP | 188404-10-6 | sc-203440 | 5 mg | $219.00 | 4 | |
This irreversible inhibitor of cytosolic phospholipase A2 can lead to a compensatory increase in group IVD sPLA2 activity due to reduced competition for substrates. | ||||||